MedTrace Logo

Molecular Signatures of HPV+ ORL Cancers (OROPAP)

NCT04189003 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 66

Last updated 2021-10-04

No results posted yet for this study

Summary

The aim of this study is to identify HPV molecular signature in head and neck cancer to establish a new classification for positive human papillomavirus oropharyngeal tumor

Conditions

  • Oropharyngeal Cancer
  • Human Papillomavirus-Related Carcinoma

Sponsors & Collaborators

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Principal Investigators

  • Hélène PÉRÉ, PhD · AP-HP, Hôpital Européen Georges Pompidou

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-06-01
Primary Completion
2020-11-30
Completion
2020-11-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04189003 on ClinicalTrials.gov